Marsh & McLennan, US5717481023

Resilient Marsh & McLennan stock holds above $190 as new institutional money arrives

Published on 08/21/2026 at 21:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Marsh & McLennan stock is drawing fresh institutional interest while trading above $190, with recent filings highlighting new stakes and a consensus view that leaves modest upside from current levels.

Architekturvisualisierung eines modernen Glashochhauses mit begrünter Plaza davor
Marsh & McLennan (ISIN US5717481023) illustriert durch modernen Architektur-Render eines gläsernen Bürohochhauses mit Vorplatz, Illustration mit AI erstellt.

Marsh & McLennan Companies Inc. (ISIN US5717481023) stock is trading solidly above the $190 mark as of August 21, 2026, while new institutional filings highlight fresh money being put to work in the shares.

Per recent market data for Marsh & McLennan Companies, Inc. under the NYSE ticker MRSH, the stock closed at $193.29 on August 21, 2026, up $1.82 or 0.95% for the session, underscoring a steady bid in the current trading environment. The MRSH quote and options overview also shows the same $193.29 level in after-hours trading on that date.

In parallel, fresh institutional activity in August 2026 signals continued confidence in Marsh & McLennan stock. One newly reported position was disclosed at a stock price of $190.26, a level that sits below the company’s 12-month high of $212.65 and above its 12-month low of $156.60, pointing to a valuation that is off the peak but well above the recent trough. An institutional filing summary on MRSH holdings reports the 12-month trading range alongside the $190.26 level where shares recently opened.

Fresh institutional stakes and insider activity

The latest flow-of-funds data around Marsh & McLennan stock in August 2026 centers on both institutional and insider moves that together deepen the picture of investor positioning.

New holdings disclosed this month include a stake valued at $16.50 million in Marsh & McLennan Companies Inc., recorded at a stock opening price of $190.26 on a recent trading day. A filing detailing a $16.50 million MRSH investment notes that the position was established when MRSH stock traded at $190.26, placing the entry point roughly $3 below the $193.29 close on August 21, 2026.

Alongside institutional buying, insider transactions add another layer of context for Marsh & McLennan stock. A director-level insider purchase disclosed for transaction date August 15, 2026 shows a buy volume that translates into a transaction size of $36,559.30, executed at an average price of $188.45 per share. A disclosure of MRSH insider share purchase details that August 15, 2026 insider trade and highlights the $188.45 per-share price, which is below both the $190.26 institutional opening level and the $193.29 close on August 21, 2026.

For investors, the spread between these entry prices and the recent close offers a quantified sense of how different classes of market participants are positioning. The director’s $188.45 purchase in mid-August 2026 now sits $4.84 below the $193.29 close on August 21, 2026, illustrating a gain for that individual transaction over a short holding period, while the $190.26 institutional entry was $3.03 below the same close.

Consensus view and valuation frame

Beyond near-term trading levels, the latest consensus view on Marsh & McLennan stock from equity research surveys paints a picture of cautious but supportive expectations.

Recent data compiled from analyst coverage indicates that Marsh & McLennan stock carries a consensus rating of Hold, paired with an average or target price level of $203.50. Consensus rating and target data for MRSH show that the $203.50 figure stands above the $193.29 close recorded on August 21, 2026, implying upside of $10.21 per share or a gain of 5.28% if the stock were to move to that target level.

A separate valuation-focused analysis of Marsh & McLennan Companies uses forecast revenue growth and earnings expansion assumptions to estimate a fair value that is also slightly ahead of the current market price. One such framework uses projected annual revenue growth of 4.1% and an increase in earnings from $4.0 billion to $5.4 billion, then arrives at a fair value estimate of $204.86 for MRSH shares. A valuation and forecast overview for Marsh & McLennan notes that this $204.86 fair value estimate sits an indicated 8% above a reference share price, positioning the stock as modestly undervalued in that particular model.

Taken together, the $203.50 consensus target and the $204.86 fair value estimate frame a valuation corridor that is several dollars above the $193.29 close on August 21, 2026. This corridor anchors expectations for mid-single-digit percentage upside if Marsh & McLennan stock were to trade closer to the levels implied by current models and consensus pricing.

Business profile and product focus

Marsh & McLennan Companies Inc. operates as a professional services firm with a focus on risk, strategy, and people, combining insurance brokerage activities with consulting capabilities in areas such as benefits and talent management. While the detailed latest quarterly fundamentals for 2026 are not fully enumerated in the current result set, the company’s earnings and cash flow narrative in recent years has centered on demand for advisory services and insurance solutions in a shifting risk landscape, paired with capital allocation choices such as share repurchases.

Within this broad business profile, Marsh & McLennan’s insurance brokerage segment is a key product and service pillar. The firm’s core offering in that area revolves around designing and placing commercial insurance programs for corporate clients, helping them manage exposures ranging from property and casualty risks to specialized lines like cyber and professional liability. In practice, this means working with clients to assess their risk profile, structuring coverage with insurers, and providing ongoing advisory support as conditions change.

On the consulting side, Marsh & McLennan’s capabilities touch human capital and benefits design. Services in that area include advising employers on health and benefits programs, retirement structures, and workforce risk management. These streams together complement the insurance brokerage activities by positioning the firm as a one-stop partner for risk and people-related strategy questions, reinforcing recurring revenue through long-term client relationships.

Stock level and investor takeaway

As of the close on August 21, 2026 at 4:00 p.m. ET, Marsh & McLennan Companies, Inc. stock traded at $193.29 on the NYSE, with the same level reflected in the immediate after-hours quote that evening. MRSH close on August 21, 2026 and options data show the unchanged after-hours figure and place that price within the previously cited 12-month range of $156.60 to $212.65.

For investors, the key numerical markers at this point are the $193.29 closing price, the institutional and insider entries at $190.26 and $188.45 respectively, and the current consensus and model-based valuation levels around $203.50 to $204.86. Together, these figures outline a scenario in which Marsh & McLennan stock is trading below recent highs but above insider and institutional purchase levels, with analyst and model-derived estimates indicating modest potential upside from today’s price corridor.

Read more

Further detail on Marsh & McLennan Companies Inc., including corporate governance documents and service descriptions, is available via the company’s own investor relations and corporate information site.

Fact box

Company: Marsh & McLennan Companies Inc.

ISIN: US5717481023

Ticker: MRSH

Exchange: NYSE

Price (as of August 21, 2026, 4:00 p.m. ET): $193.29 USD

Sector / Industry: Financials / Insurance and professional services

Disclaimer...

en | US5717481023 | MARSH & MCLENNAN | boerse | 69983289 | bgmi